imipramine has been researched along with Nocturnal Enuresis in 28 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Nocturnal Enuresis: Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination treatment of solifenacin and imipramine is a useful and safe treatment for nocturnal enuresis after failure of everything else." | 9.41 | Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study. ( Elawady, H; Mahmoud, MA; Samir, M, 2021) |
| "Nocturnal enuresis is a condition, which can affectthe quality of life in children." | 6.90 | Effect of Low Dose Imipramine in Patients with Nocturnal Enuresis, A Randomized Clinical Trial. ( Azarfar, A; Esmaeeli, M; Mostafavian, Z; Ravanshad, S; Ravanshad, Y; Zahabi, E, 2019) |
| "The combination treatment of solifenacin and imipramine is a useful and safe treatment for nocturnal enuresis after failure of everything else." | 5.41 | Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study. ( Elawady, H; Mahmoud, MA; Samir, M, 2021) |
| "The additive pharmacologic effects of imipramine with pseudoephedrine for the treatment of monosymptomatic nocturnal enuresis in children were well tolerated, and gave significantly faster results than single drug therapy using imipramine." | 5.15 | Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial. ( Abedin Zadeh, M; Kholaseh Zadeh, G; Moslemi, MK, 2011) |
| "Imipramine has been used for over four decades (early reports in 1960s) for the treatment of nocturnal enuresis, although the reason for its effect is not clear." | 3.75 | Synthesis of a quaternary bis derivative of imipramine as a novel compound with potential anti-enuretic effect. ( Faizi, M; Jamali, B; Kobarfard, F; Roodsari, MS; Shafaghi, B; Soleymani, Z, 2009) |
| "Nocturnal enuresis is a condition, which can affectthe quality of life in children." | 2.90 | Effect of Low Dose Imipramine in Patients with Nocturnal Enuresis, A Randomized Clinical Trial. ( Azarfar, A; Esmaeeli, M; Mostafavian, Z; Ravanshad, S; Ravanshad, Y; Zahabi, E, 2019) |
| "Imipramine has a proven efficiency in unselected enuretic patients, but due to its side-effect profile it is only indicated, if at all, in therapy-resistant cases." | 2.73 | Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study. ( Nevéus, T; Tullus, K, 2008) |
| "Nocturnal enuresis affects 15-20% of 5-year-old children, 5% of 10 year-old-children and 1-2% of people aged 15 years and over." | 2.44 | Nocturnal enuresis. ( Kiddoo, D, 2007) |
| "Bed wetting or nocturnal enuresis is a common problem among children." | 1.39 | Bed wetting - silent suffering: an approach to enuresis and voiding disorders in children. ( Kanitkar, M; Ramamurthy, HR, 2013) |
| "We examined whether the existence of spina bifida occulta or ultrasonographic bladder abnormalities was related to the outcome of treatment for primary nocturnal enuresis in children." | 1.34 | Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children. ( Miyazato, M; Nishijima, S; Ogawa, Y; Owan, T; Sugaya, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (32.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 5 (17.86) | 2.80 |
| Authors | Studies |
|---|---|
| Moretti, E | 1 |
| Barbosa, L | 1 |
| da Silva, IB | 1 |
| de Lima, AMJ | 1 |
| Lemos, A | 1 |
| Mello, MF | 2 |
| Locali, RF | 1 |
| Araujo, RM | 1 |
| Reis, JN | 1 |
| Saiovici, S | 1 |
| Mello, LF | 1 |
| Trigo Rocha, FE | 1 |
| Dai, R | 1 |
| Deng, C | 1 |
| Ravanshad, Y | 1 |
| Azarfar, A | 1 |
| Esmaeeli, M | 1 |
| Mostafavian, Z | 1 |
| Zahabi, E | 1 |
| Ravanshad, S | 1 |
| Samir, M | 1 |
| Mahmoud, MA | 1 |
| Elawady, H | 1 |
| Rittig, N | 1 |
| Hagstroem, S | 1 |
| Mahler, B | 1 |
| Kamperis, K | 1 |
| Siggaard, C | 1 |
| Mikkelsen, MM | 1 |
| Bower, WF | 1 |
| Djurhuus, JC | 1 |
| Rittig, S | 1 |
| Kanitkar, M | 1 |
| Ramamurthy, HR | 1 |
| Caldwell, PH | 2 |
| Deshpande, AV | 2 |
| Von Gontard, A | 1 |
| Tuncel, A | 1 |
| Mavituna, I | 1 |
| Nalcacioglu, V | 1 |
| Tekdogan, U | 1 |
| Uzun, B | 1 |
| Atan, A | 1 |
| Kiddoo, D | 1 |
| Jamali, B | 1 |
| Roodsari, MS | 1 |
| Soleymani, Z | 1 |
| Faizi, M | 1 |
| Shafaghi, B | 1 |
| Kobarfard, F | 1 |
| Abedin Zadeh, M | 1 |
| Moslemi, MK | 1 |
| Kholaseh Zadeh, G | 1 |
| Hergüner, S | 1 |
| Hergüner, A | 1 |
| Küçükapan, HU | 1 |
| Eggert, P | 1 |
| Freischmidt, S | 1 |
| Bismarck, PV | 1 |
| Schulz-Jürgensen, S | 1 |
| MEUSERT, W | 1 |
| FISHER, GW | 1 |
| MURRAY, F | 1 |
| WALLEY, MR | 1 |
| KILOH, LG | 1 |
| CERNY, L | 1 |
| KULE, J | 1 |
| DESTOUNIS, N | 1 |
| EPSTEIN, SJ | 1 |
| GUILFOYLE, FM | 1 |
| ALDERTON, HR | 1 |
| MEIJER, A | 1 |
| HAEGGLUND, TB | 1 |
| PARKKULAINEN, KV | 1 |
| Miyazato, M | 1 |
| Sugaya, K | 1 |
| Nishijima, S | 1 |
| Owan, T | 1 |
| Ogawa, Y | 1 |
| Volkers, AC | 1 |
| Heerdink, ER | 1 |
| van Dijk, L | 1 |
| Nevéus, T | 1 |
| Tullus, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Relationship Between Nocturnal Enuresis And Spina Bifida Occulta: A Prospective Controlled Trial[NCT03543995] | 330 participants (Actual) | Observational [Patient Registry] | 2017-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for imipramine and Nocturnal Enuresis
| Article | Year |
|---|---|
What do cochrane systematic reviews say about interventions for enuresis in children and adolescents? An overview of systematic reviews.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Nocturnal Enuresis; S | 2022 |
Management of nocturnal enuresis.
Topics: Adult; Antidepressive Agents, Tricyclic; Antidiuretic Agents; Behavior Therapy; Child; Child, Presch | 2013 |
Nocturnal enuresis.
Topics: Acupuncture Therapy; Age Factors; Antidepressive Agents, Tricyclic; Desipramine; Genetic Linkage; Hu | 2007 |
Medical management of nocturnal enuresis.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Antidiuretic | 2012 |
8 trials available for imipramine and Nocturnal Enuresis
| Article | Year |
|---|---|
A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
Topics: Adolescent; Child; Child, Preschool; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Imipram | 2023 |
Re: A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Nocturnal Enuresis; | 2023 |
Response to letter to the editor re a prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Humans; Imipramine; Nocturnal Enuresis; Prospecti | 2023 |
Effect of Low Dose Imipramine in Patients with Nocturnal Enuresis, A Randomized Clinical Trial.
Topics: Antidiuretic Agents; Child; Child, Preschool; Deamino Arginine Vasopressin; Drug Therapy, Combinatio | 2019 |
Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study.
Topics: Child; Deamino Arginine Vasopressin; Humans; Imipramine; Nocturnal Enuresis; Prospective Studies; So | 2021 |
Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial.
Topics: Antidepressive Agents, Tricyclic; Child; Child, Preschool; Double-Blind Method; Drug Administration | 2011 |
Differentiation of subgroups of monosymptomatic enuresis according to prepulse inhibition of the startle reflex.
Topics: Acoustic Stimulation; Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Child; Clinical | 2012 |
Tolterodine and imipramine in refractory enuresis; a placebo-controlled crossover study.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Child; Cresols; Cross-Over Studi | 2008 |
16 other studies available for imipramine and Nocturnal Enuresis
| Article | Year |
|---|---|
Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Biofeedback, Psychology; Child; Child | 2014 |
Bed wetting - silent suffering: an approach to enuresis and voiding disorders in children.
Topics: Adolescent; Algorithms; Behavior Therapy; Child; Child, Preschool; Cholinergic Antagonists; Deamino | 2013 |
Long-term follow-up of enuretic alarm treatment in enuresis nocturna.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Combined Modality Therapy; Deamino Arginine V | 2008 |
Synthesis of a quaternary bis derivative of imipramine as a novel compound with potential anti-enuretic effect.
Topics: Acetylcholine; Animals; Chemistry, Pharmaceutical; Cholinergic Antagonists; Drug Evaluation, Preclin | 2009 |
Imipramine for enuresis associated with risperidone.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Child; Humans; Imipramine; Male; Nocturnal Enure | 2011 |
[Treatment of enuresis with tofranil].
Topics: Enuresis; Humans; Imipramine; Nocturnal Enuresis; Psychopharmacology | 1961 |
A controlled trial of imipramine in the treatment of nocturnal enuresis in mentally subnormal patients.
Topics: Enuresis; Humans; Imipramine; Mental Disorders; Nocturnal Enuresis | 1963 |
[NOCTURNAL ENURESIS IN CHILDREN--IMIPRAMINE THERAPY AND ITS COMPLICATIONS].
Topics: Adolescent; Child; Drug Hypersensitivity; Enuresis; Humans; Imipramine; Mental Disorders; Nocturnal | 1963 |
[AMBULATORY TREATMENT OF NOCTURNAL ENURESIS WITH IMIPRAMINE].
Topics: Enuresis; Humans; Imipramine; Nocturnal Enuresis | 1963 |
IMIPRAMINE IN THE TREATMENT OF MENTALLY ILL ADULT ENURETICS.
Topics: Adult; Drug Therapy; Enuresis; Humans; Imipramine; Mental Disorders; Mentally Ill Persons; Nocturnal | 1964 |
IMIPRAMINE (TOFRANIL) IN THE CONTROL OF ENURESIS.
Topics: Child; Drug Therapy; Enuresis; Humans; Imipramine; Nocturnal Enuresis; Toxicology | 1965 |
IMIPRAMINE IN THE TREATMENT OF NOCTURNAL ENURESIS OF CHILDHOOD.
Topics: Biomedical Research; Child; Child Behavior Disorders; Drug Therapy; Enuresis; Humans; Imipramine; No | 1965 |
VALUE OF IMIPRAMINE FOR BEDWETTING CHILDREN.
Topics: Child; Diagnosis; Drug Therapy; Enuresis; Humans; Imipramine; Nocturnal Enuresis; Placebos | 1965 |
ENURETIC CHILDREN TREATED WITH IMIPRAMINE (TOFRANIL): A CYSTOMETRIC STUDY.
Topics: Adolescent; Child; Drug Therapy; Enuresis; Humans; Imipramine; Manometry; Nocturnal Enuresis; Physio | 1965 |
Location of spina bifida occulta and ultrasonographic bladder abnormalities predict the outcome of treatment for primary nocturnal enuresis in children.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Imipramine; Male; Nocturnal Enuresis; Risk Fact | 2007 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive A | 2007 |